Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: Case series and review of literature

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Cheng, Vincent C C ^a   Chen, Jonathan H K ^a   Tai, Josepha W M ^a   Wong, Sally C Y ^a   Poon, Rosana W S ^a   Hung, Ivan F N ^a   To, Kelvin K W ^a   Chan, Jasper F W ^a   Ho, Pak Leung ^a   Lo, Chung Mau ^a   Yuen, Kwok Yung ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Bowel preparation; Daptomycin; Decolonization; Lactobacillus rhamnosus GG; Linezolid; Polyethylene glycol; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CLINDAMYCIN; DAPTOMYCIN; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MACROGOL; MINOCYCLINE; NITROFURANTOIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIUM CARRIER; CASE REPORT; CASE STUDY; CONTROLLED STUDY; DISINFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; FECES MICROFLORA; FEMALE; HOSPITAL INFECTION; HUMAN; INTESTINE FLORA; INTESTINE PREPARATION; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT CARE; POSTOPERATIVE COMPLICATION; RISK REDUCTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; HOSPITALIZATION; MICROBIOLOGY; MIDDLE AGED;

AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; VANCOMYCIN RESISTANCE;

EID: 84907388280     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-514     Document Type: Article

References (23)

1. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005, 11(6):821-828. 10.3201/1106.041204, 3367597, 15963275.
2. Cheng VC, Tai JW, Chen JH, So SY, Ng WC, Hung IF, Leung SS, Wong SC, Chan TC, Chan FH, Ho PL, Yuen KY. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc 2014, 113(10):734-741. 10.1016/j.jfma.2014.04.001, 24796821.
3. Cheng VC, Chan JF, Tai JW, Ho YY, Li I, To KK, Ho PL, Yuen KY. Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region. Emerg Health Threats J 2009, 2:e9. 3167649, 22460290.
4. Cheng VC, Tai JW, Ng ML, Chan JF, Wong SC, Li IW, Chung HP, Lo WK, Yuen KY, Ho PL. Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J (Engl) 2012, 125(19):3450-3457.
5. Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW, Pegues DA. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008, 8(8):1737-1743. 10.1111/j.1600-6143.2008.02304.x, 18557723.
6. Cheng VC, Chan JF, Wong SC, Chen JH, Tai JW, Yan MK, Kwan GS, Tse H, To KK, Ho PL, Yuen KY. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl) 2013, 126(23):4504-4509.
7. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RH. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994, 18(2):105-109. 10.1016/0732-8893(94)90074-4, 8062527.
8. Chia JK, Nakata MM, Park SS, Lewis RP, McKee B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995, 21(6):1520. 10.1093/clinids/21.6.1520, 8749657.
9. Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999, 29(2):361-366. 10.1086/520216, 10476743.
10. Mondy KE, Shannon W, Mundy LM. Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2001, 33(4):473-476. 10.1086/321895, 11462182.
11. Brossier F, Lefrancois S, Paute J, Gouot A, Golmard JL, Chaibi P, Pautas E, Berigaud S, Drieux L, Jarlier V, Aubry A. Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. J Hosp Infect 2010, 76(4):368-369. 10.1016/j.jhin.2010.06.020, 20850898.
12. Hachem R, Raad I. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2002, 23(1):43-44. 10.1086/501968, 11868893.
13. Montecalvo MA. Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother 2003, 51(Suppl 3):iii31-iii35.
14. Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ, Porter SB, Wenzel RP. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001, 33(9):1476-1482. 10.1086/322687, 11588692.
15. Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1995, 39(3):794. 10.1128/AAC.39.3.794, 162631, 7793898.
16. Eisenstein BI, Oleson FB, Baltz RH. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis 2010, 50(Suppl 1):S10-S15.
17. Karki S, Cheng AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect 2012, 82(2):71-84. 10.1016/j.jhin.2012.07.005, 22889522.
18. Szachta P, Ignys I, Cichy W. An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol 2011, 45(10):872-877. 10.1097/MCG.0b013e318227439f, 21814146.
19. de Regt MJ, Willems RJ, Hene RJ, Siersema PD, Verhaar HJ, Hopmans TE, Bonten MJ. Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother 2010, 54(7):2801-2805. 10.1128/AAC.01765-09, 2897316, 20404120.
20. Manley KJ, Fraenkel MB, Mayall BC, Power DA. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust 2007, 186(9):454-457.
21. Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol 2010, 48(7):2595-2598. 10.1128/JCM.00473-10, 2897524, 20421444.
22. Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, Broyles J, Moore KL, Craig AS, Schaffner W. Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis 2007, 13(7):1024-1030. 10.3201/eid1307.070019, 2878236, 18214174.
23. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 2011, 52(2):228-234. 10.1093/cid/ciq113, 21288849.